Adam Heroux

Adam Heroux has extensive experience in quality assurance and regulatory affairs, with a focus on medical devices and AI technology. Adam most recently worked as the Vice President of Quality and Regulatory Affairs at Kheiron Medical, where they were responsible for the global registration of AI mammography devices and the implementation of a quality management system. Prior to that, they served as the Head of Regulatory Affairs at Overjet, leading the successful FDA clearance of an AI automated bone level annotation tool for periodontal patients. Adam has also held regulatory affairs and compliance roles at Ambra Health, Nova Biomedical, Solace Therapeutics, Boston Scientific, Biovest International, and Genzyme Biosurgery. Throughout their career, they have demonstrated expertise in developing and executing regulatory strategies, overseeing compliance and quality systems, and preparing regulatory submissions.

Adam Heroux earned their Bachelor of Science (BS) degree in Biomedical Engineering from Rensselaer Polytechnic Institute, completing their studies from 1995 to 1999. Adam then pursued further education and obtained a Master of Business Administration (MBA) degree with a focus on Organizational Leadership from Rivier University between 2008 and 2009.